Data / Form D filings / Clarametyx Biosciences, Inc.
Clarametyx Biosciences, Inc.: Form D filing
Clarametyx Biosciences, Inc., a biotechnology company in Columbus, OH, filed a Form D with the SEC in 2024. The latest, on January 19, 2024, reports $27.5 million sold of a $33.1 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1275 KINNEAR ROAD, Columbus, OH, 43212
- Phone
- (614) 686-2689
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2008752
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 19, 2024 | New notice | $33,124,959 | $27,524,145 | $5,600,814 | 7 | Jan 5, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Richards | Executive Officer | |
| Peter G. Kleinhenz | Director | |
| Michael G. Layman | Director | |
| William G. Baumel | Director | |
| Wayne G. Embree | Director | |
| Chuck G. Bramlage | Director | |
| Larry G. Edwards | Director | |
| Michael Triplett II | Director |
Other biotechnology companies in Ohio that filed recently
- LAACClamp Inc. $900,000 · Oct 5, 2026
- Autology, Inc. $3.4 million · Sep 30, 2026
Every Form D from the week of Jan 15, 2024 · All recent filings in Ohio · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Clarametyx Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.